Angel Investing in the 21st Century – Part 1-1

Early Exits Workshop – Part 1-1

Sponsored by the Angel Capital Education Foundation and the Angel Capital Association
…presented at the Angel Capital Association National Summit, San Francisco May 5, 2010

Highlights of Angel Investing in the 21st Century – Part 1-1

  • Outline of the Early Exits Workshop and how I got started on Early Exits
  • Successful investing requires two things – investing right and exiting well
  • Angels and entrepreneurs would have more fun, and make more money, if we focused more on our exits
  • Angel investing is still new – about where traditional Venture Capital investing was in the mid-1980s
  • The economy has changed and traditional Venture Capital isn’t working for today’s tech companies

Part 1-2 of Angel Investing in the 21st Century is online here.

The Exits Workshop Videos are also available on YouTube.

One thought on “Angel Investing in the 21st Century – Part 1-1”

  1. An interesting, albeit lesser known, and seemingly successful “big” acquisition was the acquisition of Pharmion by Celgene in 2008. I think it was over 2 billion, most of their IP was based on the production and use of a 50+ year old, structurally very simple, small molecule drug (5-azacytidine). That being said, the drug has ~10 years of IP coverage remaining for the indication (myodysplastic syndrome) and its sales grew by over 100% between 2010 and 2011 (~600 million to over 1.2 billion).

Leave a Reply

Your email address will not be published. Required fields are marked *

Captcha *